P.L. 112-240, American Taxpayer Relief Act of 2012 (end stage renal disease prospective payment system bundling issue)
Medicare Part B drug reimbursement issues Research and experimentation tax incentives and international tax issues, including:
Administration's FY 2013 Revenue Proposals,
Tax Reform, including House Ways and Means Discussion Draft Implementation of PL 112-029, the America Invents Act 
Trans-Pacific Partnership 12 years of data exclusivity 
ITC (International Trade Commission) Implementation of Health Care Reform, P.L 111-148, The Patient Protection and Affordable Care Act (Biosimilars)
HR 5651, the Food and Drug Administration Reform Act (Prescription Drug User Fee Act Reauthorization)
S 1387, the Food and Drug Administration Safety and Innovation Act (Prescription Drug User Fee Act Reauthorization) (Track and
Trace)
MMM - Medicare/Medicaid TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of
AMGEN, INC.
601 13th Street, NW, 11th Floor North, WASHINGTON, DC, 20005, US
L NICOLE CURRIE GREGORY PORTNER HELEN RHEE CHAKA BURGESS REBECCA MANDELL HOWARD MOON JESSE KERNS VICTORIA BLATTER WILLIAM O'BRIEN RUTH HOFFMAN NANCY ELLEN MCCARTHY (Tax Counsel, Senate Finance Committee) L NICOLE CURRIE VICTORIA BLATTER HELEN RHEE WILLIAM O'BRIEN WILLIAM O'BRIEN HELEN RHEE
Tax Counsel, Senate Finance Committee